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a b s t r a c t
Exercise-induced dyspnea is one of the most common symptoms that cause a patient to see a physician
and a broad differential diagnosis is required. In this case report, we describe a patient with this
complaint who had a left bundle branch block and preserved left ventricular function at rest. On stress
echocardiography, she had signiﬁcant exercise-induced left ventricular dysfunction and associated mitral
regurgitation but a coronary angiogram demonstrated normal coronary arteries. Both of the echocardio-
graphic ﬁndings, as well as her symptoms, improved with the placement of a bi-ventricular pacemaker.
A brief review of the literature on cardiac resynchronization therapy for indications beyond the current
guidelines is also provided.
& 2013 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.
1. Introduction
Current guidelines offer clear boundaries for cardiac resyn-
chronization therapy (CRT) [1]. However, clinicians are often
presented with patients, who although they fall just outside the
boundaries for guideline-driven therapy, present with certain
clinical characteristics that suggest that they would beneﬁt from
treatment. Herein, we describe one such case.
2. Case report
A 55 year-old female with a long-standing history of left bundle
branch block (LBBB), hypertension and hyperlipidemia presented for
evaluation of 4 years of progressive dyspnea on exertion. On evalu-
ation, she endorsed New York Heart Association (NYHA) Class III
heart failure symptoms despite being on an optimal medical regimen
(beta-blocker and angiotensin receptor blocker at maximally toler-
ated doses). She described marked dyspnea with lifting, climbing
stairs or walking short distances. The electrocardiogram revealed
sinus bradycardia at a rate of 48 beats per minute with a complete
LBBB (QRS duration of 150 ms). (Fig. 1(a)) The coronary angiogram
from an outside institution revealed normal coronary arteries.
A trans-thoracic echocardiogram revealed mild left ventricular sys-
tolic dysfunction with a low-normal ejection fraction (EF) of 50%,
stage-two diastolic dysfunction, and moderate mitral regurgitation
with a structurally normal valve at rest. Signiﬁcant ventricular
dyssynchrony was present at rest based on: (1) intraventricular mec-
hanical delay: (a) mean time-to-peak myocardial velocity of 255.83
ms (standard deviation 52.13 ms, cut-off is Z33 ms), (b) greatest
intraventricular delay (time to peak velocity difference) – posterior
base: 110 ms (cut-off is 4100 ms), and (c) aortic pre-ejection time of
150 ms (cut-off is Z140 ms); and (2) interventricular mechanical
delay of 60 ms (cut-off is Z40 ms). However the exercise stress
echocardiogram demonstrated a decrease in left ventricular ejection
fraction with exercise to 30%, with an increase in mitral regurgitation
from moderate to severe as well as an increase in right ventricular
systolic pressure from 27 to 60 mmHg although the QRS width did
not increase with exercise. The functional capacity was 5.7 metabolic
equivalents (METS) (stage 2 Bruce protocol), reaching a heart rate of
157 beats per minute (95% maximal predicted heart rate) with an
exercise duration of 4 min.
Since the mitral valve was structurally normal, it was felt that
mitral valve repair was not indicated, and given her debilitating
symptoms, in the setting of a baseline left bundle branch block
with documented dyssynchrony, she was offered a bi-ventricular
pacemaker. We hoped to improve her ventricular synchrony and
left ventricular function, particularly during exertion. A bi-ventri-
cular pacemaker and not an ICD was placed without complications
following the patient's consent since the resting EF was 50%. Her
paced electrocardiogram is demonstrated in Fig. 1(b).
At one-year follow-up, she endorsed a dramatic improvement
in her exercise capacity with NYHA Class II symptoms with
the ability to pick up her grandchild, walk up one ﬂight of stairs
and walk on level ground at a regular pace. A follow-up exercise
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echocardiogram demonstrated reduction in resting mitral regurgi-
tation to mild both at rest and during exertion as well as a
improvement in her right ventricular systolic pressure with exercise
to 42 mmHg (see Fig. 2(a) and (b) for representative ﬂow velo-
city across the tricuspid valve with exercise pre- and post-device
placement). There was also an improvement in the resting EF to
455% that was maintained during exercise with an improved
functional capacity on her repeat treadmill stress echocardiogram
with a functional capacity of 7 METS (stage 3 Cornell protocol),
6 min exercise duration and peak heart rate of 134 beats per minute
(84% maximal predicted heart rate). Her device was programed DDD
50-140.
3. Discussion
The implant of a CRT device in a patient with a resting ejection
fraction of 50% represents off-guideline use of this therapy [1].
However, since the patient's signiﬁcant NYHA Class III symptoms,
LBBB and exertional ventricular dysfunction achieved evidence-
based levels for improvement with cardiac resynchronization, a
decision was made to offer the treatment to the patient. Indeed,
the guidelines do not explicitly state that the ejection fraction
should be evaluated only at rest and this patient did meet the
ofﬁcial implantation guideline criteria if we use the exercise echo
data instead of the resting echo data. This is especially relevant as
her symptoms correlated with the echocardiographic ﬁndings.
Pathophysiologically we hypothesize that the chronotropic
response not only stressed her hemodynamic aspects of cardiac
function but caused further conduction delays that led to left
ventricular dysfunction, functional mitral regurgitation and hemo-
dynamic deterioration.
To date, there has been one other case report of a CRT implan-
tation in a patient with a normal EF at rest but with an
inter-ventricular conduction delay (IVCD) in a LBBB pattern, an
elevated pulmonary capillary wedge pressure on invasive hemo-
dynamic monitoring and left ventricular dyssynchrony measured
by pressure–volume loop-derived analysis [2]. In this case, the
patient displayed NYHA Class III symptoms that improved con-
siderably after implant.
Implantation of CRT outside of guidance-based indications is not
unique to clinical practice in the United States. A 2010 evaluation of
US usage of CRT found that almost a quarter of all CRT devices were
placed for off-society-guideline and off-FDA labeled indications,
including patients with NYHA Class I and II symptoms, QRS duration
o120 ms and EF greater than 35% (13%, 12% and 1.3% of the cohort
respectively) [3]. Although at the outset, the data may seem to
represent inappropriate practice patterns, the indications for CRT
are continually expanding and the most recent guidelines for device-
based therapy now include CRT for those with less severe heart
failure symptoms [section deleted] [1].
Although still under evaluation, there is increasing evidence
that at least three additional groups might beneﬁt from CRT: (1)
CRT for heart failure and preserved EF, (2) CRT to correct mitral
regurgitation and (3) CRT for patients with complete heart block
and preserved left ventricular function. On the other hand, while
until very recently there had been mixed evidence for CRT for
heart failure and a narrow QRS, [4–6] the ﬁndings of the EchoCRT
trial [7] strongly suggest that patients with a QRS duration of
o130 ms do not beneﬁt from forced biventricular pacing even if
they have evidence of left ventricular dyssynchrony.
Fig. 1. (a) Baseline EKG and (b) EKG with bi-ventricular pacing.
Fig. 2. (a) Right ventricular systolic pressure estimate at baseline and (b) with
bi-ventricular pacing.
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3.1. CRT for heart failure in patients with preserved EF
A retrospective re-analysis of the CRT PROSPECT database com-
prising patients with EF o35%, NYHA Class III–IV symptoms and QRS
duration 4130ms compared patients with EF 435% on re-analysis
with those with EF o35% on re-analysis and found similar outcomes
– in other words, patients with relatively preserved EF also beneﬁted
from CRT [8]. This ﬁnding is pathophysiologically consistent with that
of De Sutter et al., who found evidence of dyssynchrony in 50% of a
patient population with heart failure with preserved ejection fraction
(HFPEF) who also had a QRS duration of Z120 ms. Although these
studies did not include assessment of ejection fraction with exercise,
given the ﬁnding in this case, it would be important for future studies
of CRT for patients with preserve ejection fraction to evaluate ejection
fraction with exercise to determine if this would be a consistent
outcome.
3.2. CRT to correct mitral regurgitation
In this case report, the mitral regurgitation that occurred with
stress was likely functional due to dilation of the mitral annulus
and left ventricular cavity due to dyssynchrony. The ﬁnding that
mitral regurgitation could signiﬁcantly improve with CRT was
documented in the MIRACLE trial [9] and has been evaluated in
multiple studies since, many of which suggest that that improve-
ment in mitral regurgitation with CRT is predictive of clinical
response [10]. Kanzaki et al. helped to explain the mechanism for
this improvement by demonstrating that improved papillary
muscle insertion site timing decreases mitral regurgitation [11].
3.3. CRT for patients with heart block and mild left ventricular
function
While previous trials had speciﬁcally excluded those patients
with heart block the recent BLOCK HF trial [12] compared standard
right ventricular pacing to bi-ventricular pacing in this population
of patients with an EF of r50% and NHYH class I–III heart failure.
They found that patients assigned to bi-ventricular pacing had a
decreased combined primary end point that included: time to
death of any cause, treatment with IV therapy for heart failure
or an increased left ventricular end-systolic volume index of
Z15%. This trial suggests that if a patient has any degree of left
ventricular dysfunction at the time of pacemaker implant for heart
block with a high degree of ventricular pacing expected, they
would likely beneﬁt from CRT.
4. Conclusions
Both the data pointing to a broader population and this speciﬁc
patient's physiology and response point to the potential beneﬁts of
CRT for patients who currently fall just outside the boundaries of
the current ACC, AHA and HRS guidelines and suggest that more
prospective studies are necessary to better delineate the group of
patients who beneﬁt from CRT. In the meantime, we recommend
careful evaluation of conduction, dyssynchrony, ventricular func-
tion and mitral insufﬁciency during exertion in patients who
present with signiﬁcant exertional symptoms of heart failure
when ischemia has been eliminated as a cause. Other patients
with similar clinical features as those described above may also
beneﬁt from CRT.
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